Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Cadila gets USFDA nod for generic drug to treat Parkinson

      Cadila gets USFDA nod for generic drug to treat Parkinson

      Ruby Khatun Khatun15 Dec 2017 4:08 PM IST
      New Delhi: Cadila Healthcare said it has received approval from the US health regulator to market Pramipexole Dihydrochloride extended-release...
      Natco Pharma raises Rs 915 crore via QIP

      Natco Pharma raises Rs 915 crore via QIP

      Ruby Khatun Khatun15 Dec 2017 10:36 AM IST
      New Delhi: Natco Pharma has raised Rs 915 crore through issue of securities to qualified institutional investors (QIP), according to a regulatory...
      Lupin gets USFDA nod for generic contraceptive tablets

      Lupin gets USFDA nod for generic contraceptive tablets

      Ruby Khatun Khatun15 Dec 2017 10:30 AM IST
      New Delhi: Drug major Lupin said it has received approval from the US health regulator to market its Tydemy tablets, used to prevent pregnancy, in the...
      Glenmark completes phase 3 study for nasal spray

      Glenmark completes phase 3 study for nasal spray

      Ruby Khatun Khatun15 Dec 2017 10:15 AM IST
      New Delhi: Glenmark Pharmaceuticals said it has completed phase 3 study of its investigational fixed-dose combination nasal spray and plans to submit...
      FDA approves first drug for Eosinophilic Granulomatosis with Polyangiitis

      FDA approves first drug for Eosinophilic Granulomatosis with Polyangiitis

      Ruby Khatun Khatun15 Dec 2017 10:06 AM IST
      The U.S. Food and Drug Administration (FDA) expanded the approved use of Nucala (mepolizumab) to treat adult patients with eosinophilic granulomatosis...
      USFDA accepts application for Indivior

      USFDA accepts application for Indivior's new schizophrenia drug

      Ruby Khatun Khatun15 Dec 2017 9:45 AM IST
      U.S. Food and Drug Administration (FDA) accepted Indivior's application for its new schizophrenia treatment, the British drugmaker said on Tuesday,...
      Did Sanofi, WHO ignore warning signals on dengue vaccine?

      Did Sanofi, WHO ignore warning signals on dengue vaccine?

      Ruby Khatun Khatun15 Dec 2017 9:30 AM IST
      CHICAGO/LONDON: When French drugmaker Sanofi published the results of clinical trials of children given its dengue vaccine two years ago, the overall...
      Pharmacists with allopathic pharmacy diploma can now sell homeopathic medicines

      Pharmacists with allopathic pharmacy diploma can now sell homeopathic medicines

      Ruby Khatun Khatun14 Dec 2017 12:30 PM IST
      Chandigarh: Haryana Health Minister Anil Vij on Wednesday said that pharmacists holding allopathic pharmacy diploma and degree would now be able to...
      Cipla launches 2 digital education platforms-Ciplamed and Breathefree

      Cipla launches 2 digital education platforms-Ciplamed and Breathefree

      Ruby Khatun Khatun14 Dec 2017 11:00 AM IST
      Mumbai: In continuation to its commitment to patient-centricity and digitization, Cipla announces the launch of two digital assets, one aimed at...
      DocsApp raises 7.2 million dollars from Bessemer Venture Partners, others

      DocsApp raises 7.2 million dollars from Bessemer Venture Partners, others

      Ruby Khatun Khatun14 Dec 2017 10:53 AM IST
      New Delhi: Health-tech startup DocsApp said it has closed a funding round of USD 7.2 million from Bessemer Venture Partners (BVP) and Japanese...
      JB Chemicals and Pharma gets USFDA nod for hypertension tablets

      JB Chemicals and Pharma gets USFDA nod for hypertension tablets

      Ruby Khatun Khatun14 Dec 2017 10:30 AM IST
      New Delhi: JB Chemicals & Pharmaceuticals has received US health regulator's nod for Atenolol tablets, used in the treatment of high blood...
      IMA urges Govt to come out with ordinance reg drug prices

      IMA urges Govt to come out with ordinance reg drug prices

      Ruby Khatun Khatun14 Dec 2017 10:16 AM IST
      New Delhi: The Indian Medical Association (IMA) on Monday urged the Government to come out with an urgent ordinance for one drug-one company-one price...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok